ACTINOGEN MEDICAL ORDINARY (ACW) Short Interest
ACTINOGEN MEDICAL ORDINARY (ASX:ACW) had 0.00% of shares reported as short positions as of 16 May 2026, representing 40,618 shares. ACTINOGEN MEDICAL ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
- Short interest
- 0.00%
- Reported positions
- 40,618
- Industry
- Pharmaceuticals, Biotechnology & Life Sciences
- As of
- 16 May 2026
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
ACW
Actinogen Medical
Actinogen Medical Limited focuses on the development and commercialization of novel therapeutic compounds, specifically targeting central nervous system diseases. Positioned as an innovative player in the biotechnology sector, Actinogen's flagship product, Xanamem, aims to treat Alzheimer's Disease and other neurodegenerative conditions, offering a unique therapeutic approach in a growing market. ...